Let’s say a salamander, due to an environmental or attack-based injury, ends up losing its left foreleg. Three weeks later, a small, cone-shaped mound of new tissue will have emerged from the wound. If we give it another month, that mound will become a fully functional limb — bones, tendons, nerves, blood vessels, skin — indistinguishable from the one that was removed. Now imagine a human patient in the salamander’s place. Same injury. Same timeline. What they have three weeks later is a surgical closure, a course of antibiotics and the beginning of a prosthetic consultation.
We share common ancestry with the salamander. Our limbs are built from the same basic evolutionary blueprint. So the question isn’t merely academic: What, exactly, did we lose? And more unnervingly — did we lose it at all, or did evolution simply bury it beneath layers of immunological armor and metabolic pragmatism?
What Salamanders Have That Humans Don’t
Most people think of regeneration as an exotic superpower. In reality, it exists on a continuous biological spectrum, and humans are not entirely outside of it.
Planarian flatworms can be sliced into hundreds of fragments and each piece will grow into a complete organism. Salamanders can regenerate entire limbs, portions of their hearts and sections of their spinal cords, repeatedly throughout their adult lives. And human children, under approximately seven years of age, have also been documented regrowing cleanly amputated fingertips — skin, nail and all — provided the wound is left open and untreated.
Regeneration is not alien to mammalian biology. The question, as Jessica Whited, associate professor of stem cell and regenerative biology at Harvard, has framed it, is a precise one: “Why are mammals limited?”
When a salamander loses a limb, the sequence that follows is, at first, not unlike the human body’s. A blood clot forms. Immune cells flood the wound. Skin migrates inward to cover the exposed tissue. So far, this looks almost exactly like human wound healing.
Then everything diverges. Within hours, the wound epidermis becomes innervated by nearby nerve fibers, forming what biologists call the apical epidermal cap. This structure secretes molecular signals that trigger something extraordinary in the cells beneath it: dedifferentiation.
Mature, fully specialized cells (i.e., muscle, connective tissue, bone, etc.) essentially forget what they are. They shed their adult identities, revert to a primitive, embryonic-like state and collectively form the blastema: a proliferating mass of progenitor cells that grows, self-patterns and differentiates outward until a complete limb is restored.
A 2023 review from Whited’s laboratory, published in the Journal of Biological Chemistry, describes it as resembling “the early embryonic limb bud”: a reconstruction of the developmental program that built the original limb in the first place.
Human cells do not dedifferentiate after injury. They do not form a blastema. Without those two capabilities, everything downstream — the patterning, the regrowth, the reconstruction — is simply unavailable. The salamander re-runs its developmental program from an intermediate checkpoint. We cannot find the checkpoint, let alone run the program.
The Human Immune System’s Evolutionary Bargain
The primary reason humans cannot regenerate limbs is not a missing gene or a broken pathway. It is, in large part, a consequence of one of our greatest evolutionary achievements: a powerful, aggressive adaptive immune system.
When human tissue is severely damaged, the immune system responds with extraordinary speed. Neutrophils and macrophages flood the wound. Pro-inflammatory cytokines cascade through the body. The objective is to seal the injury, neutralize microbial threats and restore structural continuity fast. This response has kept our lineage alive through millions of years of infection and trauma. The problem is that it is biologically incompatible with regeneration.
Successful regeneration requires controlled, pro-rebuilding inflammation, orchestrated by macrophages over an extended period. A landmark 2013 study in PNAS demonstrated this precisely: depleting macrophages in axolotl salamanders immediately after amputation caused blastema formation to fail entirely. The stump scarred over with dense collagen, mimicking mammalian wound healing exactly. When macrophages were replenished and the limb re-amputated, full regenerative capacity returned.
The mammalian immune system substitutes a fast, aggressive response for the slower, morphogenetically permissive one that regeneration demands. Fibroblasts flood the wound and deposit disorganized Type I collagen, producing structurally sound scar tissue, rapidly generated and wholly incapable of supporting the reorganization a blastema requires. Subsequent studies have confirmed this pattern universally: a reduced immune response coincides with regeneration; a robust one produces scar.
Our immune system did not fail to evolve regenerative capacity. It actively traded it away, and for most of our evolutionary history, that was a rational transaction. Evolution does not optimize for elegance. It optimizes for survival. And for terrestrial, warm-blooded mammals, the conditions strongly favored fast healing over complete healing.
Consider the arithmetic of predation. A gazelle regrowing a lost leg over weeks is a sitting target. Fast scar formation and early mobility are worth far more than a perfect limb that no predator will give you the time to grow.
And then there is also the cancer problem. The cellular dedifferentiation and rapid proliferation that power blastema formation are, in molecular terms, uncomfortably close to the processes that drive tumor development. For a long-lived mammal, evolution placed a premium on tumor suppression, and that suppression appears to have come at the direct cost of regenerative permissiveness.
A 2023 peer-reviewed hypothesis adds the broadest frame: only animals that undergo larval metamorphosis tend to retain broad regenerative capacity as adults. Terrestrial vertebrates that lost the larval stage lost, with it, the selective pressure to keep regeneration online.
The Blueprint May Still Be There In Humans
For most of the 20th century, scientists assumed mammals had simply lost the genetic machinery for regeneration, that the relevant genes had decayed and were gone. That assumption now appears to be wrong.
More specifically, researchers believe that the genetic toolkit for limb regeneration is ancestral, shared across vertebrates, and likely still present in mammalian genomes — not deleted, but silenced.
A 2024 study found that placing embryonic mouse tissue in a low-oxygen environment caused it to activate the earliest molecular steps of a regenerative response, mimicking regeneration-competent frog tadpole tissue. The signaling pathways that drive regeneration in salamanders and zebrafish (Wnt/β-catenin and FGF signaling) exist in humans. They are simply not activated after adult injury.
Researchers at Tufts University and Harvard’s Wyss Institute have already shown that pharmacological intervention can re-awaken regenerative capacity in animals that have lost it — fitting amputated adult frogs with a silicone cap containing five regenerative compounds produced large-scale limb regrowth in animals that should have been incapable of it.
Full limb regeneration in humans remains decades away. But the same fibrotic processes that block limb regeneration also drive the scarring that follows a heart attack, the world’s leading cause of death. Suppression of scarring alone might be sufficient to unlock a regenerative capacity that, the evidence increasingly suggests, has been present in us all along.
The deeper lesson here may be this: evolution is not a ratchet that moves in only one direction. What was set aside under one set of selective pressures might, with the right molecular key, be recoverable. Because the blueprint did not disappear. It was simply filed away.
Missing limb regeneration is just one of many evolutionary trade‑offs made throughout human history. See how many others you can spot in my fun Evolution IQ Test.
